Gen-Probe (GPRO) Appoints New SVP, VP, and IR Director
Get Alerts GPRO Hot Sheet
Join SI Premium – FREE
Gen-Probe (Nasdaq: GPRO) today announced three changes to its leadership team in support of its future growth. Brian B. Hansen has been promoted to senior vice president, global sales and service. Michael J. Watts has been appointed vice president of LIFECODES and Prodesse; and Albert S. Kildani has joined the Company as senior director, investor relations and corporate communications.
Details:
Hansen has been with Gen-Probe for over six years and has led the Company's highly respected sales and service organization in the United States in a number of increasingly responsible roles during that time. In his new position, he will oversee the continued geographic expansion of Gen-Probe's commercial organization throughout the world.
Watts has managed Gen-Probe's investor relations and corporate communications efforts for over eight years. In his new role, he will lead the Company's efforts to profitably grow its recently acquired business units focusing on transplant diagnostics and infectious disease testing.
Kildani joins Gen-Probe after a 14-year career on Wall Street as a sell-side research analyst, investment banker, and buy-side analyst in the healthcare space with a focus on the molecular diagnostics industry. Al has strong existing relationships with many of the Company's institutional shareholders and research analysts.
Details:
Hansen has been with Gen-Probe for over six years and has led the Company's highly respected sales and service organization in the United States in a number of increasingly responsible roles during that time. In his new position, he will oversee the continued geographic expansion of Gen-Probe's commercial organization throughout the world.
Watts has managed Gen-Probe's investor relations and corporate communications efforts for over eight years. In his new role, he will lead the Company's efforts to profitably grow its recently acquired business units focusing on transplant diagnostics and infectious disease testing.
Kildani joins Gen-Probe after a 14-year career on Wall Street as a sell-side research analyst, investment banker, and buy-side analyst in the healthcare space with a focus on the molecular diagnostics industry. Al has strong existing relationships with many of the Company's institutional shareholders and research analysts.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GoPro promotes CFO Brian Tratt to senior vice president role
- Simmons Bank chief data officer Lisa Hunter to retire
- Ingredion names Diego Reynoso as CFO, effective October 2026
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share